KaliVir and Roche Enters into a Global Licensing Agreement to Discover, Develop and Commercialize Novel Oncolytic Vaccinia Viruses
Shots: KaliVir will receive an upfront payment & may be eligible to receive re...
CASI Entered into a Sublicense Agreement with Tianshi for CID-103 to Treat Autoimmune Diseases
Shots: CASI to receive a $10M up front, milestones along with royalty. Tianshi wil...
LifeArc Co-Founded Company RQ Bio Entered into a License Agreement with AstraZeneca to Develop Monoclonal Antibodies Against SARS-...
Shots: RQ Bio to receive up front & milestones of ~$157M along with royalties....
Evotec Expands 2018 Agreement with BMS for Targeted Protein Degradation Therapies
Shots: Evotec receives $200M upfront & an additional fee in performance-based,...
Twist Bioscience Enters into Multiple Agreement with Astellas to Identify Antibodies & Reduce Tumor Microenvironment-Mediated Immu...
Shots: Twist to receive an up front & additional fees upon licensing...
Byondis Entered into a Multiple Agreement with medac to Commercialize Trastuzumab Duocarmazine (SYD985) for the Treatment of Cance...
Shots: Byondis to receive an up front & will also be eligible to receive an ad...
